In total, Hemera Biosciences has raised 1.3 m. Duker is co-founder of three companies, including Hemera Biosciences, whose lead product is an anti-complement gene therapy-based treatment for dry macular.
#Hemera biosciences software
In other words, Digital Therapeutics are viewed as clinically validated software solutions used by clinicians to treat, manage, and prevent a broad spectrum of diseases and disorders. In December 2020, Janssen acquired the rights to Hemera Biosciences, LLC’s investigational gene therapy treatment: a one-time outpatient eye injection to help preserve vision in patients with late-stage, severe age-related macular degeneration. Hemera Biosciences's latest funding round in April 2013 was reported to be 1.3 m. Digital Therapeutics can positively impact the trajectory of a patient’s disease and are approved to deliver specific clinical outcomes. A digital therapeutic is typically described as an evidenced-based software solution, which are held to the same standards of regulatory oversight as more traditional medical devices. Plus, there are hundreds of thousands of wellness apps available to anyone on smartphone app stores.īut there’s a reason digital medicine and even more specifically, digital therapeutics exist in a subcategory of their own. CRISPR Therapeutics is a gene editing company focused on developing transformative gene-based medicines for the treatment of serious human diseases using its proprietary clustered, regularly interspaced short palindromic repeats associated protein-9 (CRISPR/Cas9) gene-editing platform. In 2021, the global top five players have a share approximately in terms of revenue.
#Hemera biosciences Patch
You’re likely already familiar with digital technologies such as telehealth platforms and electronic health records. The global key manufacturers of Geographic Atrophy include Apellis Pharmaceuticals, Iveric Bio, Alkeus Pharmaceuticals, Hemera Biosciences, Allegro Ophthalmics, Stealth BioTherapeutics, Gyroscope Therapeutics, Regenerative Patch Technologies and Roche, etc. Janssen didn’t disclose financial terms of its deal with Hemera Biosciences, the privately-owned biotech that’s been developing HMR59.
Digital medicine has become a major component in an ever-evolving healthcare environment.
0 kommentar(er)
